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1.96 cm3, SD 3.97) and 2 patients had femoral head cysts (4 cysts, mean
total cyst volume/patient 3.98 cm3, SD 4.10). 2½ years after surgery 13
patients had acetabular cysts (16 cysts, mean total cyst volume/patient
0.96 cm3, SD 1.70) and 2 patients had femoral head cysts (4 cysts, mean
total cyst volume/patient 0.80 cm3, SD 0.72). Mean total acetabular cyst
volume/patient decreased signiﬁcantly from 1 year to 2½ years after PAO
= 0.04. All acetabular cysts were located anterolaterally in the acetabulum
except for one that was posterolateral. The femoral head cysts were
positioned anterolaterally and anteromedially.
The radiographic evaluation on preoperative and postoperative radiographs
in the 28 hips showed that the CE angle increased from mean 13 (-27 to
35)° to mean 31 (20 to 41)° after PAO, and the AI angle decreased from
mean 18 (7 to 39)° to mean 2 (-4 to 10)°.
Conclusions: In conclusion, the radiographically measured angles demon-
strated optimal surgical correction of the acetabulum at PAO. The mean
total cyst volume/patient decreased signiﬁcantly between 1 and 2½ years
after PAO. We believe this is a result of decreased local stresses in the
subchondral bone after PAO which also indicates that redirection of the
acetabulum reduces the risk of progression of osteoarthritis in the operated
hip.
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Purpose: The pathogenesis of osteoarthritis (OA) is a complex chain of
events in the whole joint, eventually leading to pain and disability. Car-
tilage loss and overall bone remodeling are central in the progression of
OA, and have been studied in many ways. The trabecular bone structure
has been investigated mainly from high-resolution magnetic resonance
imaging (MRI), micro computed tomography (μCT), or radiographs. We
investigated the feasibility of quantifying OA-characteristic bone structure
from low-ﬁeld MRI.
Methods: The 21-month longitudinal study included 159 subjects prospec-
tively selected to include a large range of ages and degrees of OA. After
exclusion of scans due to acquisition errors, 311 knee scans were included.
The population characteristics were: age 56±16, BMI 26±4, 47% female,
and 19% with radiographic OA (Kellgren and Lawrence, KL>1). The KL score
was determined from load-bearing radiographs in semi-ﬂexed position
using the SynaFlex (Synarc). MRI scans with near-isotropic voxels were
acquired using a Turbo 3D T1 sequence from a 0.18T Esaote scanner
(40° FA, TR 50ms, TE 16ms, scan time 10 minutes, resolution 0.7mm ×
0.7mm × 0.8mm). The medial tibial cartilage compartment was segmented
automatically by a voxel classiﬁcation framework and used to determine
a region-of-interest in the subchondral medial tibia from 3 to 14 mm
below the cartilage covering a load-bearing region of the trabecular bone
(see Figure 1). A total of 534 potential bone structure features were
designed using Gaussian derivatives at multiple scales. A machine learning
based framework using cross-validation and bootstrapping was used to
automatically select the features for a linear discriminant classiﬁer in-
cluding 20 features. The resulting bone structure marker was analyzed
cross-sectionally for the ability to separate healthy and OA knees by the
area under the receiver-operator characteristics curve (AUC). The statistical
signiﬁcances of AUC scores and differences in-between were tested using
DeLong’s test.
Figure 1: Sagittal view of a knee scan. The red outlined area is the automatically extracted
ROI and the yellow outlined area is the given cartilage segmentation.
Results: Separating healthy and OA knees based on the selected bone
structure features resulted in median AUC of 0.77, p=0.0059. The best
single bone feature among the 534 features resulted in AUC of 0.73,
p=0.0166.
Conclusions: The limited spatial resolution of low-ﬁeld MRI makes direct
analysis of the trabecular rod/plate structure infeasible. However, the re-
sults demonstrated the possibility of separating healthy and OA knees from
the tibial bone structure. It was possible to quantify a trabecular structure
marker related strongly to the presence of OA. Furthermore, selecting a set
of appropriate features demonstrated better results than including the best
single bone structure feature.
More research is needed to determine the clinical features that this marker
describes - potential candidates are bone marrow lesions, growth zone
characteristics, or possibly even textural patterns related to the rod/plate
ratio even if the individual trabeculae are not visible.
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Purpose: Loss of muscle strength, particularly in the quadriceps, and
impairment of functional capacity are common characteristics of people
with knee osteoarthritis (OA), which is a painful, chronic and progressive
condition. Patients with OA are characterised by increased inﬂammation
and sensitized nerves, resulting in increased pain. To date, studies have
focused on the inﬂammatory responses within the synovial membrane,
synovial tissues and articular chondrocytes, yet the inﬂammatory pathology
in skeletal muscle is not clear. The aim of this study was to examine the
effect of severe OA on inﬂammatory genes in skeletal muscle that regulate
muscle mass compared to asymptomatic older people
Methods: Participants: 19 patients (mean ± SEM, age 69.9±1.5 year
and BMI =29.9±0.9 kg·m-2) with severe knee OA scheduled for knee
replacement surgery, 17 age-matched asymptomatic (MA) older people
(age= 66.7±1.8 year, BMI=29.8±1.2 kg·m-2) and 12 asymptomatic young
(Y) individuals (age 25.1±1.1 year, BMI 23.6±1.0 kg·m-2). Muscle samples
from the vastus lateralis were taken from patients with knee OA during
their knee replacement surgery, and from the MA and Y using a needle
biopsy technique, at rest and in a fasting state. Real-time polymerase chain
reaction (RT-PCR) was performed to measure the mRNA abundance for the
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pro-inﬂammatory and catabolic cytokines; MCP-1, TNF-α, IL-1β and genes
encoding proteins linked to atrogenesis including; SOCS3 and atrogin-1.
Results: OA patients had signiﬁcantly greater levels of the pro-
inﬂammatory cytokines MCP-1 mRNA (Fig 1A) and TNF-α mRNA (Fig.
1B), compared to both MA and Y individuals. OA also tended to have
higher levels of IL-1β mRNA and SOCS3 mRNA, compared to MA but these
differences did not reach statistical signiﬁcance (p>0.05). No signiﬁcant
differences were observed between asymptomatic MA and asymptomatic Y
with the exception of MCP-1 (Fig. 1A).
Figure 1. Differences in MCP-1 (A), TNF-α (B), IL-1β (C), SOCS3 (D) and Atrogin-1 (panel
E) between people with severe knee osteoarthritis (OA), aged and BMI matched asymp-
tomatic individuals (MA) and young (Y) asymptomatic individuals. * indicates p<0.05 be-
tween MA and OA groups. #indicates p<0.05 between Y and OA. ˆindicates p<0.05 be-
tween Y and MA.
Conclusions: Cytokines were implicated in OA, yet also feature in catabolic
disease states in which muscle loss is a feature. The current study
demonstrates that OA resulted in a signiﬁcant increase gene expression of
numerous muscle inﬂammatory markers, compared to asymptomatic aged
and BMI-matched peers. Ageing had little effect on muscle inﬂammation
(MA versus Y).
Given the importance of inﬂammatory-mediated mechanisms in muscle
atrophy, the impact of the increased inﬂammatory markers may be exerting
on muscular mass and function in OA required further analysis.
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Purpose: Synovial inﬂammation may play a role in the progression of
joint destruction in osteoarthritis (OA). Activation of synoviocytes by pro-
inﬂammatory stimuli results in the release of biochemical mediators such
as matrix metalloproteinases (MMPs), chemokines, cytokines etc. We have
previously shown that heme oxygenase-1 (HO-1) induction down-regulates
MMPs and HMGB1 in OA synoviocytes. In this study we aim to evaluate the
effects of the HO-1 pathway on cell migration and chemokine production
as well as the signaling pathways involved.
Methods: Synovial tissue samples were obtained from 15 osteoarthritic pa-
tients undergoing total knee joint replacement. Synoviocytes were obtained
by digestion with collagenase and cultured until third passage. Cells were
treated with the HO-1 inducer cobalt protoporphyrin IX (CoPP, 10 μM) or
the CO-releasing molecule CORM-2 (100 μM) in the presence or absence of
IL-1β (10 ng/ml). HO-1 gene silencing was achieved by speciﬁc HO-1 siRNA.
Gene expression was analyzed by quantitative PCR and protein expression
by Western Blot and ELISA. Migration assay was performed using transwell
chambers.
Results: Treatment of synoviocytes with CoPP signiﬁcantly decreased both
mRNA and protein expression of CCL2 and CCL20 chemokines, with a weak
effect on IL-8 levels. Conversely, CORM-2 treatment signiﬁcantly decreased
protein levels of IL-8, CCL2 and CCL20. HO-1 down-regulation by siRNA
counteracted the effects of HO-1 induction. Interestingly, the reduction on
chemokine levels by either CoPP or CORM-2 was accompanied by a signif-
icant reduction in the migration index elicited by IL-1β. We observed that
CoPP treatment signiﬁcantly decreased ERK 1/2 and JNK phosphorylation,
whereas CORM-2 markedly diminished the phosphorylation of ERK1/2, JNK
and p38.
Conclusions: Taken together, our data show the inhibitory effect of the
HO-1 pathway, either by direct induction of HO-1 or by the release of CO, a
metabolite of the reaction catalized by HO-1, on chemokine production and
cell migration. These effects may be dependent on the inhibition of MAPK
phosphorylation. These data support our previous results and suggest that
targeting the HO-1 pathway may represent a potential strategy to control
OA progression.
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Purpose: Osteoarthritis is characterized by degeneration of articular car-
tilage and intra-articular inﬂammation in response to cytokines such
as IL-1beta or TNFalpha. These cytokines increase the synthesis of
prostaglandin E2 (PGE2) by stimulating cyclooxygenase (COX)-2, microso-
mal PGE synthase-1 (mPGES-1), and secreted phospholipase A2 (sPLA2).
NSAIDs provide symptomatic relief, but none has conclusive eﬃcacy as
a disease modifying anti-osteoarthritic drug with non negligeable side
effects. Inhibiting the PGE2 production in cartilage without affecting the
COX1-COX2 balance could be of interest in order to replace traditional
NSAIDs whose side effects are not in accordance with a long-term use.
Group IIA secreted/synovial PLA2 (GIIAPLA2) is an enzyme involved in
the synthesis of eicosanoids such as PGE2. PGE2 is the main eicosanoid
contributing to extra-cellular matrix degradation in cartilage diseases.
Methods: We designed, by molecular modeling, 7 novel analogs of
3-{4-[5(indol-1-yl)pentoxy]benzyl}-4H-1,2,4-oxadiazol-5-one (termed C1),
an inhibitor of GIIAPLA2. Molecular dynamics studies were performed on
a series of complexes between “C derivatives” (C1 to C8) and GIIAPLA2.
The C1 to C8 molecules were obtained by chemical synthesis and their
GIIAPLA2 inhibitory activities were tested using in vitro PLA2 enzymatic
tests. We then tested the most promising compound (C8) in rabbit articular
chondrocytes treated by IL-1beta: we evaluated the cytotoxicity of C8 by
using a MTT-based test, we quantiﬁed its capacity to inhibit IL-1beta-
stimulated PGE2 and NO secretion, and we tested its effect on the COX1,
COX2 and iNOS protein levels.
Results: Modeling predicted that some derivatives would display greater
GIIAPLA2 aﬃnities than C1. These predictions were conﬁrmed by in vitro
PLA2 enzymatic tests. Compound C8, endowed with the most favorable
energy balance, was shown experimentally to be the strongest GIIAPLA2
inhibitor. Moreover, C8 displayed an anti-inﬂammatory activity on rabbit
articular chondrocytes, as shown by its capacity to inhibit IL-1beta-
stimulated PGE2 secretion by these cells. Moreover, depending on the
culture conditions, C8 had no effect or a slight effect on IL-1beta-stimulated
NO secretion. In addition, C8 did not modify the COX1, COX2, iNOS protein
levels.
Conclusion: In conclusion, C8 appears as a potential candidate for new
anti-inﬂammatory drug in joints, implying a better tolerance.
